Cargando…
Sponsorship of oncology clinical trials in the United States according to age of eligibility
BACKGROUND: The sponsorship mix of trials relevant to young people with cancer has not been reported. Understanding this sponsorship mix may have implications for policies and regulations related to pediatric cancer drug development. METHODS: We analyzed sponsorship of interventional trials first op...
Autores principales: | Neel, Dylan V., Shulman, David S., Ma, Clement, Bourgeois, Florence, DuBois, Steven G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333829/ https://www.ncbi.nlm.nih.gov/pubmed/32351000 http://dx.doi.org/10.1002/cam4.3083 |
Ejemplares similares
-
Early Termination of Oncology Clinical Trials in the United States
por: Zhang, Ellen, et al.
Publicado: (2022) -
Off‐label prescribing of targeted anticancer therapy at a large pediatric cancer center
por: Lim, Mir, et al.
Publicado: (2020) -
Retrospective evaluation of single patient investigational new drug (IND) requests in pediatric oncology
por: Shulman, David S., et al.
Publicado: (2021) -
The Effects of Industry Sponsorship on Comparator Selection in Trial Registrations for Neuropsychiatric Conditions in Children
por: Dunn, Adam G., et al.
Publicado: (2013) -
Project sponsorship
por: Englund, Randall L, et al.
Publicado: (2015)